Prime Medicine, Inc. (PRME)

NASDAQ

$4,00

$+0,42

(+11,59%)

Previous Close: ⁦$3,58⁩

Market Closed

Prime Medicine, Inc. (PRME) Live Price Chart

Last updated: ⁦2026-10-10 16:49:00⁩. Prices reflect the latest closing data and will resume updating on the next trading day. Stock price data is sourced from Massive.

Summary

Prime Medicine, Inc. (PRME) operates in the BIOLOGICAL PRODUCTS, (NO DIAGNOSTIC SUBSTANCES) sector and is listed on NASDAQ. The stock is currently priced at $4,00, with a market capitalisation of $649,33M and a P/E ratio of --. Over the past 52 weeks, its price has ranged from $2,67 to $6,65. This page covers its latest market performance, valuation, price trends and company information.

Key Market Data

Market Cap	$649,33M
Open	$3,57
Day's High	$21,73
Day's Low	$1,11
Previous Close	$3,58
Volume	7,63M
Average Volume	3,38M
P/E Ratio	--
52-Week High	$6,65
52-Week Low	$2,67
Dividend Yield	--
Earnings Date	--

Prime Medicine, Inc. (PRME) Latest Closing Stock Price

Prime Medicine, Inc. (PRME) last closed at $3,58 as of 2026-10-10 00:00:00, unchanged from the previous close of $3,58.

During the latest regular trading session, PRME traded between $1,11 and $21,73, with a volume of 7,63M shares. The closing price was near the lower end and near the middle of its 52-week range.

Prime Medicine, Inc. (PRME) 7-Day Stock Price Change

Over the past seven days, Prime Medicine, Inc. (PRME) moved from $2,99 to $4,00, representing a gain of 33,61% ($1,01).

The stock traded between $2,88 and $4,14 during the period. The latest price is near the upper end of the 7-day range, indicating strong upward.

The average daily volume was 6,95 million shares, up versus the previous seven-day period, indicating higher trading activity.

PRME 52-Week Price Position

Position in Range: 33,3%

52W Low$2,67

52W High$6,65

PRME is currently trading at $4,00, placing it 33,3% of the way from its 52-week low of $2,67 to its 52-week high of $6,65. This percentage reflects the stock's relative position within its 52-week trading range, not its valuation or future performance.

What is Prime Medicine, Inc. (PRME)?

Prime Medicine Inc is a biotechnology company focused on developing a new class of genetic medicines designed to provide durable, and potentially curative, treatment options for patients with diseases driven by defined genetic alterations, acquired cellular dysfunction, or dysregulated gene expression. Its program, PM577 for Wilson Disease, is designed to initially correct the H1069Q mutation in the ATP7B gene and is supported by preclinical data showing targeted correction and restoration of copper homeostasis in animal models. In addition, PM647 is being developed for alpha-1 antitrypsin deficiency, or AATD, another liver targeted disease with substantial unmet need.

Prime Medicine, Inc. Information

Industry	BIOLOGICAL PRODUCTS, (NO DIAGNOSTIC SUBSTANCES)
Employees	146
Exchange	NASDAQ
Company Website	https://www.primemedicine.com

How to Buy Prime Medicine, Inc. (PRME) Stock on MEXC

Eligible investors can buy real shares of Prime Medicine, Inc. (PRME) through MEXC RealStocks. Follow these three steps to open a RealStocks account, transfer USDT, and place a US stock order.

Step 1: Open and Verify Your RealStocks Account

Log in to the MEXC App, go to Trade → RealStocks, and select Open Account. Complete the required account-opening and identity verification process with MEXC's partner licenced broker.

Step 2: Transfer USDT to Your RealStocks Account

Go to Wallets → RealStocks and transfer USDT from your Spot Account to your RealStocks Account. RealStocks are quoted in USD, while account funding can be completed using USDT.

Step 3: Search for PRME and Place Your Order

Open the RealStocks trading page and search for PRME. Select a market or limit order, enter the price and quantity as required, review the order details, and submit your order. Once filled, the corresponding real shares will be held in your RealStocks Account.

Frequently Asked Questions (FAQ)

1.What is Prime Medicine, Inc. (PRME) share price today?

Prime Medicine, Inc. (PRME) is currently trading at $ 4,00, up 11,59% ($0,42) from the previous close of $ 3,58. Intraday prices update in real time during regular trading hours.

2.Is PRME stock going up or down today?

As of 2026-10-10 00:00:00, PRME is trading at $ 4,00, up 11,59% ($0,42) from its previous close of $ 3,58. The stock has traded between $ 1,11 and $ 21,73 during today’s regular session. Past price movements do not guarantee future results.

3.What is PRME pre-market price?

As of 2026-10-10 00:00:00, PRME is trading at $ 3,65 in pre-market trading, up 1,96% ($0,07) from the previous close of $ 3,58. Pre-market prices reflect trading activity before the regular session opens and may experience lower liquidity and higher volatility.

4.What is PRME after-hours price?

As of 2026-10-10 00:00:00, PRME is trading at $ 3,99 in after-hours trading, up 11,34% ($0,41) from the regular-session close of $ 3,58. After-hours prices may differ from the regular session's opening price due to lower liquidity and wider bid-ask spreads.

5.Is PRME stock trading now?

PRME trades on the NASDAQ exchange during regular hours, Monday through Friday, 9:30 AM to 4:00 PM ET, excluding public holidays. Pre-market and after-hours trading are also available through select brokers outside these hours.

6.Where does PRME sit relative to its 52-week high and low?

Over the past 52 weeks, PRME has traded between a low of $ 2,67 and a high of $ 6,65. At $ 4,00, the stock is positioned 33,3% of the way from its 52-week low to its 52-week high, providing context for its current price within the one-year trading range.

7.What sector is Prime Medicine, Inc. in?

Prime Medicine, Inc. (PRME) operates in the BIOLOGICAL PRODUCTS, (NO DIAGNOSTIC SUBSTANCES) sector. Sector classification helps investors compare it with companies exposed to similar market trends and competitive conditions.

8.What is Prime Medicine, Inc.'s market capitalisation and where is it listed?

Prime Medicine, Inc. is listed on the NASDAQ exchange with a market capitalisation of $ 649,33M. Market cap reflects the total market value of all outstanding shares and is commonly used to classify stocks by size.

9.How is PRME valued in terms of P/E ratio and EPS?

PRME trades at a P/E ratio of --, based on trailing-twelve-month EPS of $ -1,04. P/E ratio compares the stock price to earnings per share and is a common starting point for assessing valuation relative to peers.

10.Does Prime Medicine, Inc. pay a dividend?

Prime Medicine, Inc. pays an indicated annual cash dividend of $ 0,00 per share, with a current dividend yield of 0,00% based on the latest share price. Dividend policies are subject to change at the board's discretion.